Brookstone Capital Management Gsk PLC Transaction History

Brookstone Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$42.05 - $47.77 $1.25 Million - $1.42 Million	29,622 Added 147.51%	49,703 $2.1 Million
Q1 2022 Apr 12, 2022	SELL	$40.23 - $47.74 $1.01 Million - $1.2 Million	-25,049 Reduced 55.5%	20,081 $933,000
Q4 2021 Jan 11, 2022	BUY	$38.88 - $45.31 $14,152 - $16,492	364 Added 0.81%	45,130 $1.98 Million
Q3 2021 Nov 03, 2021	BUY	$38.79 - $43.16 $20,093 - $22,356	518 Added 1.17%	44,766 $1.74 Million
Q2 2021 Jul 14, 2021	BUY	$36.52 - $41.46 $991,737 - $1.13 Million	27,156 Added 158.88%	44,248 $1.79 Million
Q1 2021 Apr 16, 2021	BUY	$34.27 - $40.01 $266,586 - $311,237	7,779 Added 83.53%	17,092 $610,000
Q4 2020 Jan 13, 2021	BUY	$34.07 - $39.94 $43,064 - $50,484	1,264 Added 15.7%	9,313 $343,000
Q3 2020 Oct 13, 2020	BUY	$38.11 - $42.99 $306,747 - $346,026	8,049 New	8,049 $303,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.